Alternate Health Club vs GetRelief Rx
An in-depth comparison of two leading GLP-1 Providers
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
Alternate Health Club
Best for patients who want compounded GLP-1 bundled with structured workout and dietary plans, at a competitive monthly price, and who are comfortable verifying state coverage + billing terms directly with the platformStarting at $129/mo
GetRelief Rx
Best for buyers specifically seeking sublingual (non-injectable) compounded GLP-1 drops who understand the bioavailability trade-offs and lack of human PK data for this formulationStarting at $179/mo
Side-by-Side Comparison
| Feature | Alternate Health Club | GetRelief Rx |
|---|---|---|
| Overall Score | ✓7.3/10 | 6.1/10 |
| Starting Price | ✓$129/mo | $179/mo |
| Editorial Rating | ✓3.7 ★ /5 | 3.1 ★ /5 |
| Features | ✓6 features | 5 features |
| States Available | 0 | 0 |
| Compounded | ✓ Yes | ✓ Yes |
| Brand Name | — | — |
| FSA/HSA Accepted | — | — |
| FDA Warnings | None | None |
Pros & Cons
Alternate Health Club
Pros
- ✓$129/month compounded semaglutide is in the cheapest decile of the US compounded telehealth market
- ✓$169/month compounded tirzepatide is competitive with established compounded-tirz platforms
- ✓Complimentary workout & dietary plans included alongside medication — most peer platforms don't bundle this
- ✓LegitScript Verified seal displayed in the footer
- ✓U.S.-licensed clinicians explicitly mentioned
Cons
- ✗Parent company / legal entity name NOT publicly disclosed — material YMYL transparency gap
- ✗State of incorporation NOT disclosed
- ✗Per-state availability NOT enumerated — verify your state ships before committing
- ✗Pharmacy partners NOT publicly named — material YMYL transparency gap
- ✗Lab work NOT clearly disclosed as included
- ✗Billing cadence (monthly vs quarterly vs annual) NOT clearly disclosed on home page
- ✗First-month discount or trial offer NOT disclosed
GetRelief Rx
Pros
- ✓Both compounded semaglutide and tirzepatide available at publicly displayed pricing — no login wall to see costs
- ✓BBB accredited with A rating (March 2026); NPI 1306697834 is independently verifiable
- ✓Free online assessment — no upfront consultation fee before prescribing decision
Cons
- ✗SUBLINGUAL ONLY — no injectable option. Sublingual compounded semaglutide and tirzepatide have NOT been tested in human pharmacokinetic studies; mouse models suggest 5-8x higher doses needed to match subcutaneous bioavailability. Readers should understand this is NOT the same delivery method studied in STEP/SURMOUNT trials.
- ✗REGULATORY FLAG: GetReliefRX continues to offer compounded tirzepatide as of April 2026, after FDA ended enforcement discretion for tirzepatide compounding (March 19, 2025 for 503B, April 22, 2025 for 503A). The legal basis may be state-level exemptions, but this is not publicly disclosed on the site.
- ✗No LegitScript, PCAB, or NABP certifications identified — BBB accreditation is not a pharmacy-specific compliance credential
- ✗Prescriber credentials are described generically as 'licensed clinicians' without specifying MD/DO/NP/PA breakdown
Our Verdict
Alternate Health Club edges out GetRelief Rx with a higher overall score of 7.3/10 and is particularly strong for patients who want compounded GLP-1 bundled with structured workout and dietary plans, at a competitive monthly price, and who are comfortable verifying state coverage + billing terms directly with the platform. GetRelief Rx remains a solid alternative, especially if you're looking for buyers specifically seeking sublingual (non-injectable) compounded GLP-1 drops who understand the bioavailability trade-offs and lack of human PK data for this formulation.
Glossary references
Key terms in this article, linked to their canonical definitions.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Wegovy®, Ozempic®, and Rybelsus® are trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are trademarks of Eli Lilly and Company. All other product names and trademarks referenced on this page belong to their respective owners. WeightLossRankings.org is not affiliated with any pharmaceutical manufacturer. See trademark disclaimer.